Goserelin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00014 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | amenorrhea (disease) | KG + DL |
| 2 | renal hypoplasia (disease) | KG + DL |
| 3 | renal hypoplasia, bilateral | KG + DL |
| 4 | cervix endometriosis | KG + DL |
| 5 | gelatinous drop-like corneal dystrophy | KG + DL |
| 6 | duodenogastric reflux | KG + DL |
| 7 | endometriosis in cutaneous scar | KG + DL |
| 8 | endometriosis of rectovaginal septum and vagina | KG + DL |
| 9 | duodenal obstruction | KG + DL |
| 10 | duodenal ulcer (disease) | KG + DL |
| 11 | infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | KG + DL |
| 12 | aromatase excess syndrome | KG + DL |
| 13 | pelvic organ prolapse | KG + DL |
| 14 | ovarian endometriosis | KG + DL |
| 15 | obsolete susceptibility to ischemic stroke | KG + DL |
| 16 | female genital tuberculosis | KG + DL |
| 17 | physiological sexual disorder | KG + DL |
| 18 | dysplasia of cervix | KG + DL |
| 19 | precocious puberty | KG + DL |
| 20 | hypoalphalipoproteinemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.